Promotion by dichloroacetic acid and trichloroacetic acid of N-methyl-N-nitrosourea-initiated cancer in the liver of female B6C3F1 mice

Cancer Letters

Volumn 102, Issue 1-2, 1996, Pages 133-141

  Pereira, Michael A ^a,b   Phelps, J Barry ^a  

^a Environmental Health Research and Testing   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Carcinogenesis; Dichloroacetic acid; Liver cancer; Trichloroacetic acid; Tumor promotion

Indexed keywords

DICHLOROACETIC ACID; DRINKING WATER; GLUTATHIONE TRANSFERASE; METHYLNITROSOUREA; TRICHLOROACETIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; LIVER CARCINOGENESIS; MOUSE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; TUMOR PROMOTION;

ANIMALIA;

EID: 0029872439     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04156-0     Document Type: Article

References (33)

1. Uden, P.C. and Miller, J.W. (1983) Chlorinated acids and chloral in drinking water. J. Am. Water Works Assoc., 75, 524-527.
2. Krasner, S.W., McGuire, M.J., Jacangelo, J.G., Patania, N.L., Reagen, K.M. and Ajeta, E.M. (1989) The occurrence of disinfection by-products in U.S. drinking water. J. Am. Water Works Assoc., 81, 41-53.
3. Elcombe, C.R. (1985) Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment. Arch. Toxicol., 8 (Suppl.), 6-17.
4. Dekant, W., Metzler, M. and Henschler, D. (1984) Novel metabolites of trichloroethylene through dechlorination reactions in mice and humans. Biochem. Pharmacol., 33, 2021-2027.
5. Goldsworthy, T.L. and Popp, J.A. (1987) Chlorinated hydrocarbon-induced peroxisomal enzyme activity in relation to species and organ carcinogenicity. Toxicol. Appl. Pharmacol., 88, 225-233.
6. Odum, J., Green, T., Foster, J.R. and Hext, P.M. (1988) The role of trichloroacetic acid and peroxisome proliferation in the differences in carcinogenicity of perchloroethylene in the mouse and rat. Toxicol. Appl. Pharmacol., 92, 103-112.
7. Herren-Freund, S.L., Pereira, M.A., Khoury, M.D. and Olson, G. (1987) The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic and dichloroacetic acid, in mouse liver. Toxicol. Appl. Pharmacol., 90, 183-189.
8. Bull, R.J., Sanchez, I.M., Nelson, M.A., Larson, J.L. and Lansing, A.J. (1990) Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology, 63, 341-359.
9. DeAngelo, A.B., Daniel, F.B., Stober, J.A. and Olson, G.R. (1991) The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol., 16, 337-347.
10. Rapson, W.H., Nazar, M.A. and Butsky, V.V. (1980) Mutagenicity produced by aqueous chlorination of organic compounds. Bull. Environ. Contam. Toxicol., 24, 590-597.
11. Herbert, V., Gardner, A., and Coleman, N. (1980) Mutagenicity of dichloroacetate, an ingredient of some formulations of pangamic acid (tradename 'vitamin B15'). Am. J. Clin. Nutr., 33, 1179-1182.
12. Chang, L.W., Daniel, F.B. and DeAngelo, A.B. (1992) Analysis of DNA strand breaks induced in rodent liver in vivo, hepatocytes in primary culture, and a human cell line by chlorinated acetic acids and chlorinated acetaldehydes. Environ. Mol. Mutagen., 20, 277-288.
13. Waskel, L. (1978) Study of the mutagenicity of anesthetics and their metabolites. Mutat. Res., 57, 141-153.
14. Anna, C.H., Maronpot, R.R., Pereira, M.A., Foley, J.F., Malarkey, D.E. and Anderson, M.W. (1994) Ras protooncogene activation in dichloroacetic acid-, trichloroethylene-and tetrachloroethylene-induced liver tumors in B6C3F1 mice. Carcinogenesis, 15, 2255-2261.
15. Ferreira-Gonzalez, A., DeAngelo, A.B., Nasim, S. and Garrett, C.T. (1995) Ras oncogene activation during hepatocarcinogenesis in B6C3F1 male mice by dichloroacetic and trichloroacetic acids. Carcinogenesis, 16, 495-500.
16. Elcombe, C.R., Rose, M.S. and Pratt, I.S. (1985) Biochemical, histological, and ultrastructural changes in rat and mouse liver following the administration of trichloroethylene: possible relevance to species differences in hepatocarcinogenicity. Toxicol. Appl. Pharmacol., 79, 365-376.
17. Vesselinovitch, S.D. and Mihailovich, N. (1983) Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. Cancer Res., 43, 4253-4259.
18. Vesselinovitch, S.D. (1987) Certain aspects of hepatocarcinogenesis in the infant mouse model. Toxicol. Pathol., 15, 221-228.
19. Vesselinovitch, S.D., Rao, K.V.N., Mihailovich, N., Rice, J.M. and Lombard, S. (1974) Development of broad spectrum of tumors by ethylnitrosourea in mice and the modifying role of age, sex, and strain. Cancer Res., 34, 2530-2538.
20. Fujii, K. (1991) Evaluation of the newborn mouse model for chemical tumorigenesis. Carcinogenesis, 12, 1409-1415.
21. Dragani, T.A., Manenti, G., Galliani, G. and Della Porta, G. (1985) Promoting effects of 1,4-bis[2-(3,5-dichloropyridyloxy) benzene in mouse hepatocarcinogenesis. Carcinogenesis, 6, 225-228.
22. Ward, J.M., Rice, J.M., Creasia, D., Lynch, P. and Riggs, C. (1983) Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice. Carcinogenesis, 4, 1021-1029.
23. Klaunig, J.E., Weghorst, C.M. and Pereira, M.A. (1988) Effect of phenobarbital on diethylnitrosamine and dimethylnitrosamine induced hepatocellular tumors in male B6C3F1 mice. Cancer Lett., 42, 133-189.
24. Standeven, A.M. and Goldsworthy, T.L. (1993) Promotion of preneoplastic lesions and induction of CYP2B by unleaded gasoline vapor in female B6C3F1 mouse liver. Carcinogenesis, 14, 2137-2141.
25. Weghorst, C.M. and Klaunig, J.E. (1989) Phenobarbital promotion in diethylnitrosamine-initiated infant B6C3F1 mice: influence of gender. Carcinogenesis, 10, 609-612.
26. Hatayama, I., Nishimura, S., Narita, T. and Sato, K. (1993) Sex-dependent expression of class pi glutathione S-transferase during chemical hepatocarcinogenesis in BC3F1 mice. Carcinogenesis, 14, 537-538.
27. Diwan, B.A., Lubet, R.A., Ward, J.M., Hrabie, J.A. and Rice, J.M. (1992) Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy) benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with N-nitronitrosodiethylamine. Carcinogenesis, 13, 1893-1901.
28. Evans, J.G., Collins, M.A., Lake, B.C. and Butler, W.H. (1992) The histology and development of hepatic nodules and carcinoma in C3H/He and C57BL/6 mice following chronic phenobarbitone administration. Toxicol. Pathol., 20, 585-594.
29. 1) mice and nitrofen-fed mice. J. Natl. Cancer Inst., 65, 937-948.
30. Marsman, D.S. and Popp, J.A. (1994) Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643. Carcinogenesis, 15, 111-117.
31. Bursch, W , Lauer, B., Timmermann-Trosiener, 1., Barthel, G., Schuppler, J. and Schulte-Hermann, R. (1984) Controlled cell death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis, 5, 453-458.
32. Bursch, W., Paffe, S., Putz, B., Barthel, G. and Schulte-Herman, R. (1990) Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis, 11, 847-853.
33. Schulte-Hermann, R., Timmermann-Trosiener, I., Bartel, G. and Bursch, W. (1990) DNA synthesis, apoptosis and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res., 50, 5127-5138.